口服术前用药缓解非手术根管治疗后疼痛的系统综述与网状Meta分析
与安慰剂相比,泼尼松龙30-40 mg在6、12、24小时疼痛评分降低最显著,但证据质量极低至中等。基于有限低质量证据,推荐吡罗昔康或泼尼松龙用于控制术后疼痛。
要点
- 泼尼松龙30-40 mg在6、12、24小时降低疼痛评分最优,但证据质量极低至中等。
- 吡罗昔康在12和24小时显著减轻疼痛,舒林酸、酮咯酸、布洛芬在6小时显著。
- 基于有限低质量证据,可推荐吡罗昔康或泼尼松龙用于NSRCT术后疼痛控制。
核心结论
- 基于有限且低质量证据,口服吡罗昔康或泼尼松龙可推荐用于控制非手术根管治疗后疼痛。
- 需更多高质量试验确认结果。
研究设计与样本
- 系统综述与网状Meta分析,方案注册于PROSPERO(CRD42017071899)。
- 检索MEDLINE和EBSCOhost至2017年6月,无语言限制。
- 纳入评估成人NSRCT前口服药物(单用或联用)对比其他药物、安慰剂或无治疗的随机对照试验。
- 排除非干预、非牙髓、动物研究和综述。
主要发现
- 与安慰剂相比,皮质类固醇(泼尼松龙30-40 mg)在降低术后疼痛方面排名最佳:6小时疼痛评分中位差(MD)=-18.14(95%CI -32.90至-3.37);12小时MD=-22.17(95%CI -36.03至-8.32);24小时MD=-21.50(95%CI -37.95至-5.06)。
- 非甾体抗炎药在药物中排名最低,证据质量极低。
- 基于化学名的补充分析显示,舒林酸、酮咯酸和布洛芬在6小时显著减轻疼痛,而吡罗昔康和泼尼松龙在12和24小时显著减轻疼痛。
- 依托度酸在减轻疼痛方面效果最差。
- 总体证据质量为中等至极低。
关键数值与推荐
- 泼尼松龙30-40 mg对比安慰剂:6小时疼痛评分MD=-18.14(95%CI -32.90至-3.37),证据质量极低。
- 泼尼松龙30-40 mg对比安慰剂:12小时疼痛评分MD=-22.17(95%CI -36.03至-8.32),证据质量中等。
- 泼尼松龙30-40 mg对比安慰剂:24小时疼痛评分MD=-21.50(95%CI -37.95至-5.06),证据质量极低。
临床怎么用
- 对于成人非手术根管治疗,可考虑术前口服吡罗昔康或泼尼松龙以控制术后疼痛。
- 需向患者说明证据质量有限,决策应结合临床具体情况。
局限性
- 结论基于有限且低质量证据,需更多高质量试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This review aimed to find the most effective oral premedication in reducing pain in adults after nonsurgical root canal therapy (NSRCT) using network meta-analysis. METHODS: The review protocol was registered in the PROSPERO database (CRD42017071899). A literature search was performed in the MEDLINE and EBSCOhost databases until June 2017 with no language restriction. Randomized controlled trials evaluating the efficacy of oral premedications, whether given alone or in combination, compared with other agents, placebo, or no treatment in adult patients before NSRCT for postoperative pain were included. Nonintervention studies, nonendodontic studies, animal studies, and reviews were excluded. The quality of the studies was assessed using the revised Cochrane risk of bias tool. Pair-wise meta-analysis, network meta-analysis, and quality of evidence assessment using the Grading of Recommendations Assessment, Development and Evaluation criteria was performed. RESULTS: Eleven studies comparing pharmacologic groups of medications were included in the primary analysis. Compared with placebo, corticosteroids (prednisolone 30-40 mg) was ranked best for reducing postoperative pain (median difference [MD] = -18.14 [95% confidence interval (CI), -32.90 to -3.37] for the pain score at 6 hours; MD = -22.17 [95% CI, -36.03 to -8.32] for the pain score at 12 hours; and MD = -21.50 [95% CI, -37.95 to -5.06] for the pain score at 24 hours). However, the evidence was very low (6 and 24 hours) to moderate quality (12 hours). Nonsteroidal anti-inflammatory drugs were ranked least among the medications, and the quality of this evidence was very low. Additional analysis based on the chemical name showed that sulindac, ketorolac, and ibuprofen significantly reduced pain at 6 hours, whereas piroxicam and prednisolone significantly reduced the pain at 12 and 24 hours. Etodolac was found to be least effective in reducing pain. Overall, the evidence was of moderate to very low quality. CONCLUSIONS: Based on the limited and low-quality evidence, oral premedication with piroxicam or prednisolone could be recommended for controlling postoperative pain after NSRCT. However, more trials are warranted to confirm the results with a higher quality of evidence.
引用
- Nagendrababu V, Pulikkotil SJ, Jinatongthai P, et al. Efficacy and Safety of Oral Premedication on Pain after Nonsurgical Root Canal Treatment: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. J Endod. 2019. PMID: 30737050. doi:10.1016/j.joen.2018.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。